AI Regulatory Intelligence for Medical Devices
| Global Regulatory Watch | LEXQARA
AI-assisted regulatory intelligence for medical devices. Global regulatory watch, curated sources, actionable reports. Free setup + 3 free reports over a 3-month period.
What is the LEXQARA AI Regulatory Watch?
LEXQARA AI Regulatory Intelligence is an AI-assisted regulatory monitoring service for medical device companies. It helps identify relevant regulatory updates from authoritative sources and converts them into decision-ready reports with applicability assessment, impact analysis, recommended actions, and QMS-ready evidence.
✅ Worldwide regulatory monitoring
✅ Curated authoritative sources
✅ QMS-ready impact reports
✅ AI-assisted screening
Monitor
Regulations, guidance, standards, authority communications and safety information.
Assess
Identify wheter updates are relevant o your products , markets, and company role.
Act
Receive clear recommandations, to supporrt QMS, tecnical documentation, PMS, labeling, vigilance or registration actions.
Objectives of LEXQARA AI-Based Regulatory Watch
Stay ahead of new and revised regulations, guidance, standards, and authority communications with an AI-assisted regulatory intelligence service built for medical device manufacturers and economic operators.
What you get: targeted monitoring + clear impact analysis + a report you can use to document decisions and launch compliance actions.
Who is this service for?
Monitor regulatory changes affecting your products, QMS, technical documentation, PMS, labeling or market access.
Save time and avoid missing important regulatory updates when preparing CE marking, UKCA marking, FDA strategy, or international expansion.
Support manufacturers, authorized representatives, importers, distributors and suppliers with documented regulatory surveillance.
Transform regulatory monitoring into structured evidence and action plans
Regulatory monitoring is essential — but time-consuming
Medical device companies must stay informed of new and revised regulations, guidance documents, standards, authority communications, and safety information. However, manual monitoring can
be time-consuming,
be inconsistent
require resources
difficult to document
The LEXQARA solution
LEXQARA screens a curated set of authoritative sources to identify new or revised regulatory information.
Updates are assessed according to your selected countries, product scope, company role, and product status.
Involve your team exclusively for the impact assessment decision
Structured and customized report with source links, summary of changes, possible impact
What sources can be monitored?
LEXQARA monitors a curated and regularly updated set of authoritative sources depending on your selected countries, product scope, and regulatory needs.
✅ Regulations and legal texts
Guidance documents
Medical device authority communications
Authority publications
Recognized national organizations
Standards or standard lists
Market access and registration updates
More than 5,000 sources are monitored worldwide, depending on your regulatory scope and selected markets.
How it works?
1) Contact us
Tell us your countries, product scope, company role(s), and regulatory priorities.
2) Free setup and preliminary regulatory watch test
LEXQARA defines the regulatory watch scope and source strategy for your company. A preliminary regulatory watch can also be performed over a previous period to verify the accuracy of the monitoring, assess the relevance of identified updates, and confirm that the watch meets your expectations.
3) Continuous monitoring (AI-assisted)
Relevant sources are screened to identify new or revised regulatory updates.
4) Regulatory Intelligence Reports (decision-ready)
You receive decision-ready reports with source links, summary, applicability assessment. The report template can also be customized for direct integration into your QMS.
What’s inside each Regulatory Intelligence Report?
Each report helps you to:
-
Retain or discard documents (with justification)
-
Document surveillance evidence (audit-ready)
-
Trigger an action plan (QMS / technical documentation / PMS / labeling) when deemed required
Introductory offer (no commitment)
Free setup and a free trial 3 free regulatory intelligence reports over 3 months No engagement / no obligation during the first 3 months
After 3 months, you can continue with a paid plan (fees below).
Frequently Asked Questions (FAQ)
Regulatory intelligence is the structured monitoring and interpretation of regulatory changes, guidance, standards, and authority communications that may affect medical device compliance, market access, QMS processes, technical documentation, PMS, labeling, or registration activities.
Medical device manufacturers need to stay informed of regulatory changes and determine whether updates affect their products, QMS or obligations.
No. The service can be configured for the countries you want such as, EU, UK , US, Canada, Australia, Brazil, Switzerland, China, Taiwan, Mexico, and other regulatory frameworks depending on the selected countries and scope. LEXQARA can configured the service for all countries where your devices are marketed.
Yes. The reports are designed to support documented regulatory surveillance decisions, including retain/discard justification, applicability assessment or impact analysis.
Yes. The report template can be customized to support integration into your QMS, technical documentation, PMS process, or internal regulatory intelligence procedure.
Sources may include regulations, guidance documents, authority communications, standards-related updates, safety information, or market access requirements.
LEXQARA sets up your regulatory watch scope free of charge and provides 3 regulatory intelligence reports over 3 months with no commitment.
Do you want to learn more about this service?
Email: alexandre.petiard@lexqara.com or rehema.mussanzi@lexqara.com